Position in MGTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$89,720,774
+$32,209,160 QoQ
Shares Held
6,641,064
0.0% QoQ
Ownership
6.91%
of shares outstanding
% of Portfolio
11.23%
of 13F equity value
Holder Rank
#4
of 156 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JOHNSON & JOHNSON holds $757,781,542 across 11 Biotechnology names. MGTX ranks #3 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
2,449,183 | $300,220,852 | |
| 2 | NBTX |
Nanobiotix S.A.
|
5,623,816 | $212,017,863 | |
| 3 | MGTX |
MeiraGTx Holdings plc
This page
|
6,641,064 | $89,720,774 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
1,784,517 | $74,360,823 | |
| 5 | CTNM |
Contineum Therapeutics, Inc.
|
1,979,173 | $32,438,645 | |
| 6 | LEGN |
Legend Biotech Corp
|
814,586 | $23,525,243 | |
| 7 | XNCR |
Xencor Inc
|
748,062 | $12,043,798 | |
| 8 | FATE |
Fate Therapeutics Inc
|
3,379,064 | $9,123,472 |
All Filings in MGTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $89,720,774 | 6,641,064 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $57,511,614 | 6,641,064 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $52,796,458 | 6,641,064 | Shares | Defined | 2026-03-18 | |
| 2025-09-30 | $54,655,956 | 6,641,064 | Shares | Defined | 2026-03-18 | |
| 2025-06-30 | $43,299,737 | 6,641,064 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $45,026,413 | 6,641,064 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $40,444,079 | 6,641,064 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,693,236 | 6,641,064 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $27,958,879 | 6,641,064 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $40,311,258 | 6,641,064 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $46,620,269 | 6,641,064 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $32,607,624 | 6,641,064 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $44,627,950 | 6,641,064 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $34,334,300 | 6,641,064 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $43,299,737 | 6,641,064 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $24,376,805 | 2,898,550 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $21,942,023 | 2,898,550 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $40,144,917 | 2,898,550 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $68,811,577 | 2,898,550 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $38,202,889 | 2,898,550 | Shares | Defined | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||